A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell...

Area of Science:

• Genomics
• Oncology
• Biomarker Discovery

Background:

• Clear cell renal cell carcinoma (ccRCC) presents significant survival challenges, particularly with metastasis.
• Identifying reliable biomarkers is crucial for predicting ccRCC aggressiveness and drug resistance.

Purpose of the Study:

• To evaluate existing gene signatures for ccRCC prognosis.
• To develop and validate a novel, highly predictive gene signature for ccRCC patient outcomes.

Main Methods:

• Utilized ccRCC cohorts from TCGA-KIRC and ICGC-RECA.
• Applied Cox regression survival models and feature selection methods, including mRMR.
• Performed functional and differential gene expression analyses.

Main Results:

• A novel 13-gene signature (AR, AL353637.1, DPP6, FOXJ1, GNB3, HHLA2, IL4, LIMCH1, LINC01732, OTX1, SAA1, SEMA3G, ZIC2) was established.
• The signature demonstrated strong predictive power (ROC AUC 0.82) and generalized across cohorts.
• Enrichment in pathways like Urothelial Carcinoma and Chronic Kidney Disease was observed.

Conclusions:

• The 13-gene signature offers superior predictive ability and generalization for ccRCC prognosis.
• This biomarker can aid in clinical decision-making for patient care and follow-up.
• Identified gene clusters associated with poor prognosis, highlighting potential therapeutic targets.